Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001626199-14-000001
Filing Date
2014-11-25
Accepted
2014-11-24 18:19:46
Documents
1
Effectiveness Date
2014-11-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8598
  Complete submission text file 0001626199-14-000001.txt   9637
Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700
N30 Pharmaceuticals, Inc. (Filer) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-228991 | Film No.: 141247437